magnetic flow meter (Nihon Kohden tube probe type, MF-2 and constructive probe type, MF-5), the pulse rate tachometer (Nihon Kohden, RT-2), the ink-writing oscillograph (Nihon Kohden, RM-150), the perfusion pump (Sigma motor, Zero Max T6SH), the thermocouple flow meter (crossed thermocouple type, Shinei Denki, Shincorder, CTE 120) and the force-displacement transducer (Nikon Kohden, SB-IT) were used.
Experiments with dogs
Dogs were anesthetized by the administration of sodium secobarbiturate into the vein of the forelimb at the dose of 30 to 35 mg/kg, followed by the maintence dose of 2 to 5 mg/kg i.v. when necessary. The anesthetized dog was fixed on the operation desk on the back position, and heparinized (300 U/kg, i.v.), followed by the maintenance dose of 100 U/kg i.v. every 60 minutes.
Measurernent of the blood flow in the femoral and coronary arteries
The adult male dog was anesthetized, fixed and heparinized by the method as men tioned above. Then, the right femoral artery was perfused with the blood supplied through the tube connected with the left femoral artery, and the left coronary artery was perfused with the blood supplied from the right femoral artery through the special cannula accord ing to the technique of Yago (3) . The perfused flow was measured by the electromagnetic flowmeter.
The respiration was measured with the respirometer, the blood pressure in the brachial artery as the systemic blood pressure with the electronic manometer and the heart rate with the pulse rate tachometer. All of them were recorded with the ink-writing oscillograph. Y-3506 administered through the tube inserted into the left femoral vein.
Per cent increase of the blood flow was calculated by the following formula:
Increase ('/o) a-b b x 100 a: Maximum blood flow after the administration test compound b: Mean blood flow before the administration Effective dose (ED) was obtained graphically from the dose response curve as the dose corresponding to 50% increase of the blood flow.
Perfusion pressure in the femoral vessel
In the same technique as in measurement of the blood flow in the femoral artery, the right femoral artery was perfused with the blood supplied through the 4 mm polyethylene tube in diameter connected with the left femoral artery. A perfusion pump was setted in the tube between the probes of the electromagnetic flow meter (MF-2) and the electro nic manometer, these being linked through the circuit of the polyethylene tube. Perfusion pressure under working of the pump was adjusted to the pressure before the treatment. Systemic blood pressure was obtained from the brachial artery. The 0.1 ml solution con taining Y-3506 at several doses was administered into the femoral artery through the poly ethylene tube.
Measurement of the blood flow in the muscle
The muscle gastrocnemius in the right hind-leg of the dog was exposured, and the wire-type probe of the thermocouple flow meter was inserted into the tissue along its muscle fibre at relatively shallow position, then the skin was sutured. The porbe was supplied 0.3 A for heating. The femoral arterial blood flow in the same leg of the dog was also measured at the sane time with the electromagnetic flow meter (MF-5).
Systemic blood pressure was obtained from the femoral artery. All of these were recorded with the ink-writing oscillograph. The value of the blood flow in the muscle was obtained in IN. The test compound was administered intravenously.
Measurement of the cerebral hood ,flow
According to the method of Wakisaka et al. (4) , the anesthetized dog was laid on its back, and the cervical incision was made widely along the midline. All main arteries and their branches in the cervix were separated from the circumscribed tissues, and ligated except the right and left carotid artery. The circuit was made between the common caro tid and internal carotid arteries with the probes of the electromagnetic flow meter (MF 2) and the electromanometer. Y-3506 and reference compounds were injected into the femoral vein through the polyethylene cannula. The result was showed as per cent in crease of the blood flow calculated by the same formula as in the femoral blood flow. Experiments with the isolated organs 1. Anti-acetvlcholine effect (guinea pig, ileum) The isolated ileum was suspended in Tyrode's solution bubbled with air at 32 C. The tension on each preparation was approximately 0.5 g. According to the method of Van Rossum (6), the inhibitory effect of the compounds on the ACh-induced contraction of the ileum represented as pA, value for competitive antagonisms and as pD,' value for non competitive antagonisms. 2. Anti-norepinephrine and anti-epinephrine effect a) Anti-norepinephrine effect (guinea pig, i'as dejerens)
The preparation was suspended and tested in the same manner described in the term of Anti-ACh. The inhibitory effects of the compounds on the norepinephrine-induced contraction at the concentration of 3 v 10' g/ml were represented as inhibitory concent ration (1C;,,; 1,eg/ml) corresponding to 50,, decrease in the contraction in comparison with the control. b) Anti-epinephrine effect (rat, vas dejerens) The experiment was carried out in the same procedure as mentioned above. Ac 3. Anti-epinephrine and anti-barium effect (guinea pig, aorta strip)
According to the method of Furchgott (7), the screw-shaped preparation of the de scending aorta was suspended in Tyrode's solution bubbled with air at 37 C. The ten sion of the preparation was approximately 0.5 g. Epinephrine (3 10-' g'ml) and barium chloride (5 >. 10' g;' nil) were used as the spasmogen. The result was represented as 1C.,,, in the same manner described 2.a).
Experiments with the am ial preparations
According to the method of Nose et al. (8) The blood flow in the femoral artery was increased by test and reference compounds administered intravenously (Table 1 -a and b, Fig. 1 ).
Y-3506 showed a remarkable effect to increase the femoral blood flow, which appeared at a dose of 2.5 /ig; kg or more. The blood flow was increased immediately after the in jection and the effect was dependent on the dose amount (Table I -a and Fig. 1 ), and lasted for 3 to 4 minutes.
There were little influences on the respiration, the systemic blood pressure, the coronary blood flow and the heart rate each measured simultaneously (Fig. 2 (Fig. 4) .
As shown in Table 2 , piperoxan, isoxsuprine and papaverine also increased the muscle blood flow similarly as Y-3506. The reponse each of these three compounds was the same as in the femoral blood flow measured simultaneously.
(1) Effect on the cerebral circulation
The increasing effect on the cerebral blood flow of Y-3506 appeared at dose of 10 to 25 jig/ kg, lasting for about 2 minutes (Fig. 5 ).
Isoxsuprine and papaverine also increased the cerebral blood flow. As shown in Table 3 and Fig. 6 , the effect of isoxsuprine was more potent than that of Y-3506, though 2. Effect on the systemic blood pressure Y-3506 had no effect on the systemic blood pressure at the dose lower than 10 tag/kg.
The systemic blood pressure was fall slightly at doses of 50 1 g/kg, and at a high dose of 250 /cg/kg it was lowered by 4.7 per cent (Table 1 -a, Figs. 2 and 9 ).
Nylidrin, isoxsuprine and piperoxan decreased the systemic blood pressure at a dose of 2.5 jig/kg. Butylsympatol and papaverine decreased the systemic blood pressure at a dose each of 50 and 1001 g/kg (Table 1- a and b, Fig. 9 ).
Hypotensive effect each of Y-3506, piperoxan, isoxsuprine and papaverine administer ed intravenously was transient, the effect each of nylidrine and butylsympatol lasted for 5 to 10 minutes.
FIG. 9. Effects of Y-3506 (-s-) , isoxsuprine (-x-), piperoxan (--V-), nylidrin ( L ), papaverine ( []--)
and butylsympathol (--0-) on systemic blood pressure in anesthetized dogs.
3. Effect on the heart rate Y-3506 had little effect on the heart rate at the dose lower than 2.5 lIg/kg. At doses of 5 to 10 ,ecg/kg, the heart rate was increased slightly and transiently, and was increased by about 20 % at a dose of 250 fIg/kg. Nylidrin, isoxsuprine and piperoxan increased the heart rate at a dose of 1.0 to 2.5 ,ug/kg. Butylsympatol and papaverine increased the heart rate at the dose of 25 and 50 ptg/kg, respectively. Although the increasing effects on the heart rate of Y-3506, piperoxan and isoxsuprine were transient, those of nylidrin, butylsympatol and papaverine lasted for 5 to 10 minutes. It is known that the effects of isoxsuprine and piperoxan on the systemic blood pres sure are weak in general [Goodman (10) ]. However, the hypotensive effect of these com pounds was more potent than that of Y-3506. The effect of isoxsuprine was weakened at the dose higher that 50 jig/kg, and in piperoxan the dose-response curve became flat at doses of 10 to 100 /ag/kg. These phenomena may be attributed to their hypotensive effects in the systemic blood pressure.
There is a close relation between the systemic blood pressure and the peripheral blood flow. The decrease in the systemic blood pressure influences directly on the peripheral blood flow [Garattini (9) ]. In this aspect, the dose corresponding to 10% decrease of the systemic blood pressure (A) and the dose corresponding to 50% increase of the femoral blood flow (B) were obtained graphically from each doseresponse curve (Figs. 1 and 9), and then the ratio between the two values was calculated. This ratio was expressed as the therapeutic index. As shown in Table 5 , therapeutic index of Y-3506 was more than 56.8, and this value was the largest of all the compounds tested. It was suggested that beneficial effect to increase the blood flow was expected in Y-3506. Y-3506 increased the cerebral blood flow at the dose of 10 ,.cg/kg i.v. or more. The potency was higher than that of papaverine. The activity of this compound to increase the peripheral blood flow may be due to decrease of resistance of the peripheral vessels.
The compound showed little influence at the effective dose on the coronary blood flow, on the systemic blood pressure or on the heart rate.
In the preparation of the isolated organs, Y-3506 had an antispasmodic action like papaverine and an a-adrenergic receptor blocking activity, and had negative ino and chronotropic actions in the preparation of the isolated atria.
